Trials / Unknown
UnknownNCT02669485
The Impact of Indocyanine Green-enhanced Fluorescence Imaging on Bowel Transection in Left-sided Colorectal Resection
A Prospective Study to Investigate the Impact of Using Indocyanine Green-enhanced Fluorescence Imaging on the Location of Bowel Transection in Patients Undergoing Left-sided Colorectal Resection
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- The University of Hong Kong · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to evaluate the impact of fluorescence imaging on the location of colorectal transection lines based on evaluation of perfusion with indocyanine green, how it's going to affect surgical planning and its possible benefits in reducing anastomotic leakage.
Detailed description
During surgery, the line of intended bowel transection would be determined by the surgeon. Then the anesthesiologist will administer a bolus of 5mg ICG intravenously (2.5mg/ml, 2ml), followed by 10ml normal saline flush. The perfusion of colon will be assessed via fluorescence angiography. The actual bowel transection, after ICG fluorescence study, would be compared with the intended bowel transection site. The difference in terms of distance and either more proximal or distal is recorded. Then bowel anastomosis is completed in the usual manner.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | indocyanine green | Injection of indocyanine green and using fluorescence imaging to assess perfusion of bowel before bowel transection and anastomosis |
| DEVICE | Fluorescence imaging |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-06-01
- Completion
- 2017-12-01
- First posted
- 2016-02-01
- Last updated
- 2016-02-01
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT02669485. Inclusion in this directory is not an endorsement.